[go: up one dir, main page]

MX2018015647A - Metodo para producir derivado de difenilmetano. - Google Patents

Metodo para producir derivado de difenilmetano.

Info

Publication number
MX2018015647A
MX2018015647A MX2018015647A MX2018015647A MX2018015647A MX 2018015647 A MX2018015647 A MX 2018015647A MX 2018015647 A MX2018015647 A MX 2018015647A MX 2018015647 A MX2018015647 A MX 2018015647A MX 2018015647 A MX2018015647 A MX 2018015647A
Authority
MX
Mexico
Prior art keywords
diphenylmethane derivative
producing
synthesis
synthesis pathway
linear
Prior art date
Application number
MX2018015647A
Other languages
English (en)
Other versions
MX385640B (es
Inventor
Choi Soongyu
Kyoon Yoon Hee-
Hwan PARK Se-
Jeong Seo Hee
Sung Yoon Ji-
Jung Park Eun-
Kong Younggyu
Seop Song Kwang-
Ju Kim Min
Ok Park So
Original Assignee
Daewoong Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60664449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018015647(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daewoong Pharmaceuticals Co Ltd filed Critical Daewoong Pharmaceuticals Co Ltd
Publication of MX2018015647A publication Critical patent/MX2018015647A/es
Publication of MX385640B publication Critical patent/MX385640B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un método mejorado para producir un derivado de difenilmetano que es eficaz como un inhibidor del cotransportador de glucosa dependiente de sodio (SGLT), el método siendo realizado por medio de un método de síntesis convergente en el que cada grupo principal es sintetizado por separado y luego acoplado. Como tal, en comparación con un método de síntesis lineal descrito en documentos existentes, la vía de síntesis es compacta y el rendimiento puede aumentarse, y los factores de riesgo inherentes a la vía de síntesis lineal pueden reducirse. Además, la forma cristalina del compuesto producido de conformidad con el método tiene excelentes características fisicoquímicas y, por lo tanto, puede utilizarse eficazmente en campos tales como la fabricación de productos farmacéuticos.
MX2018015647A 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano. MX385640B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160075910 2016-06-17
PCT/KR2017/006271 WO2017217792A1 (ko) 2016-06-17 2017-06-15 다이페닐메탄 유도체의 제조방법

Publications (2)

Publication Number Publication Date
MX2018015647A true MX2018015647A (es) 2019-04-11
MX385640B MX385640B (es) 2025-03-18

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018015647A MX385640B (es) 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano.
MX2021008988A MX392177B (es) 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021008988A MX392177B (es) 2016-06-17 2017-06-15 Metodo para producir derivado de difenilmetano

Country Status (29)

Country Link
US (2) US10640496B2 (es)
EP (2) EP3473621B1 (es)
JP (4) JP6763978B2 (es)
KR (2) KR102233229B1 (es)
CN (2) CN113651803B (es)
AU (1) AU2017285813B2 (es)
CA (2) CA3081033C (es)
CL (1) CL2018003645A1 (es)
CO (1) CO2018014018A2 (es)
DK (2) DK3473621T3 (es)
DO (1) DOP2018000287A (es)
EC (1) ECSP19000185A (es)
ES (2) ES2898336T3 (es)
HR (1) HRP20211670T8 (es)
HU (1) HUE056428T2 (es)
MA (2) MA44545B2 (es)
MX (2) MX385640B (es)
MY (1) MY203941A (es)
NZ (1) NZ749398A (es)
PE (2) PE20240590A1 (es)
PH (1) PH12018550206A1 (es)
PL (2) PL3473621T3 (es)
PT (2) PT3473621T (es)
RS (1) RS62550B1 (es)
SA (2) SA521422474B1 (es)
SG (2) SG11201811154QA (es)
SI (1) SI3663292T1 (es)
TN (1) TN2018000437A1 (es)
WO (1) WO2017217792A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
ES2980368T3 (es) * 2018-08-13 2024-10-01 Daewoong Pharmaceutical Co Ltd Método para producir un intermediario útil para la síntesis de inhibidor de SGLT
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
EP4112612B1 (en) 2020-02-27 2025-10-22 Daewoong Pharmaceutical Co., Ltd. Intermediate useful for synthesis of sglt inhibitor and method for preparing sglt inhibitor using same
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
US12448360B2 (en) * 2020-09-10 2025-10-21 Daewoong Pharmaceutical Co., Ltd. Synthesis method for preparing SGLT inhibitor intermediate
CN113200860B (zh) * 2021-04-29 2024-07-30 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
KR20230046784A (ko) * 2021-09-30 2023-04-06 주식회사 대웅제약 이나보글리플로진을 포함하는 약학 조성물
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044194A (ko) * 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정
KR20240044190A (ko) * 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
JP2025532992A (ja) 2022-09-29 2025-10-03 デーウン ファーマシューティカル カンパニー リミテッド エナボグリフロジンを含む心血管老化疾患の予防又は治療用薬学組成物{pharmaceutical composition for preventing or treating cardiovascular aging diseases containing enavogliflozin}
MA71282A1 (fr) 2022-10-05 2025-12-31 Daewoong Pharmaceutical Co., Ltd. Composition pharmaceutique pour la prévention ou le traitement d'une néphropathie et/ou du diabète sucré, comprenant de l'énavogliflozine
EP4631498A1 (en) 2022-12-21 2025-10-15 Daewoong Therapeutics Inc. Eye drop-type pharmaceutical composition containing envogliflozin
KR20240107660A (ko) 2022-12-30 2024-07-09 주식회사 대웅제약 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물
KR102837941B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102837948B1 (ko) * 2024-11-13 2025-07-25 대웅바이오(주) 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법
KR102853437B1 (ko) * 2024-11-13 2025-09-04 대웅바이오(주) 연속반응 공정을 이용한 이나보글리플로진 합성방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
CN103214471B (zh) * 2003-08-01 2018-02-06 田边三菱制药株式会社 具有钠依赖型葡萄糖转运体抑制活性的化合物的制备方法
ATE530558T1 (de) 2007-07-26 2011-11-15 Lexicon Pharmaceuticals Inc Verfahren und verbindungen zur herstellung von natriumglucose-co-transporter-2-hemmern
MX2011001062A (es) * 2008-07-30 2011-03-24 Ferrer Int Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno.
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (en) * 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combination of sglt2 inhibitor and a sugar compound for the treatment of diabetes
TR201903445T4 (tr) * 2011-06-01 2019-03-21 Green Cross Corp Sglt2 i̇nhi̇bi̇törleri̇ olarak yeni̇ di̇feni̇lmetan türevleri̇
US9340521B2 (en) * 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PE20190467A1 (es) 2019-04-04
HUE056428T2 (hu) 2022-02-28
SA518400666B1 (ar) 2021-11-30
RU2019101056A3 (es) 2020-07-17
CO2018014018A2 (es) 2019-03-08
HRP20211670T1 (hr) 2022-02-18
ES2898336T3 (es) 2022-03-07
US10889574B2 (en) 2021-01-12
MA44545B2 (fr) 2020-11-30
CN109311861A (zh) 2019-02-05
WO2017217792A1 (ko) 2017-12-21
MX2021008988A (es) 2022-05-05
JP2021152054A (ja) 2021-09-30
JP6763978B2 (ja) 2020-09-30
PH12018550206A1 (en) 2019-09-30
SA521422474B1 (ar) 2023-11-02
MA44545A1 (fr) 2019-10-31
CA3026756C (en) 2021-03-02
PL3663292T3 (pl) 2022-01-17
PL3473621T3 (pl) 2022-01-10
SG10201911782RA (en) 2020-02-27
ECSP19000185A (es) 2019-01-31
PT3473621T (pt) 2021-10-04
CN113651803B (zh) 2022-10-28
EP3473621A4 (en) 2020-03-11
RS62550B1 (sr) 2021-12-31
CN109311861B (zh) 2021-08-24
CA3081033C (en) 2022-04-12
MA50774B1 (fr) 2022-02-28
JP7352509B2 (ja) 2023-09-28
MY203941A (en) 2024-07-25
RU2019101056A (ru) 2020-07-17
PT3663292T (pt) 2021-11-08
KR20210036892A (ko) 2021-04-05
CA3081033A1 (en) 2017-12-21
EP3473621B1 (en) 2021-08-04
AU2017285813A1 (en) 2019-01-17
CN113651803A (zh) 2021-11-16
DK3473621T3 (da) 2021-09-06
KR20170142904A (ko) 2017-12-28
TN2018000437A1 (en) 2020-06-15
US20190382390A1 (en) 2019-12-19
NZ749398A (en) 2020-01-31
JP7773506B2 (ja) 2025-11-19
CA3026756A1 (en) 2017-12-21
KR102233229B1 (ko) 2021-03-29
MX385640B (es) 2025-03-18
JP2023145481A (ja) 2023-10-11
EP3663292A1 (en) 2020-06-10
DK3663292T3 (da) 2021-10-25
AU2017285813B2 (en) 2020-02-06
JP2019521985A (ja) 2019-08-08
BR112018076243A2 (pt) 2019-03-26
PE20240590A1 (es) 2024-03-21
KR102379584B1 (ko) 2022-03-29
RU2021129636A (ru) 2021-11-22
SG11201811154QA (en) 2019-01-30
MX392177B (es) 2025-03-19
SI3663292T1 (sl) 2022-01-31
ES2891825T3 (es) 2022-01-31
US10640496B2 (en) 2020-05-05
DOP2018000287A (es) 2019-03-31
US20190169174A1 (en) 2019-06-06
MA44545B1 (fr) 2020-05-29
MA50774A1 (fr) 2021-03-31
JP2020117528A (ja) 2020-08-06
EP3473621A1 (en) 2019-04-24
HRP20211670T8 (hr) 2022-03-18
CL2018003645A1 (es) 2019-03-22
JP7669206B2 (ja) 2025-04-28
EP3663292B1 (en) 2021-09-01

Similar Documents

Publication Publication Date Title
MX2018015647A (es) Metodo para producir derivado de difenilmetano.
MX2021005598A (es) Sintesis mejorada del intermedio clave del compuesto inhibidor de g12c de kras.
CL2019002297A1 (es) Inhibidores de mnk sustituidos con piperidina y métodos relacionados con los mismos.
BR112016012883A2 (pt) Métodos e composições para aprimorar o rendimento de milho
BR112017020993A2 (pt) compostos, processo para a síntese de compostos, composição, uso de um composto da fórmula i, método para combater fungos fitopatogênicos, e, semente.
MX369525B (es) Métodos para mejorar la produccion de rebaudiosido d y rebaudiosido m.
MX2015015312A (es) Proceso para la sintesis de 5-hidroximetilfurfural a partir de sacaridos.
CU24354B1 (es) Procedimiento de obtención de derivados de tetrafluoropropilmorfolina
MX2016013557A (es) Produccion de 4-metil-tetrahidropiranos 2-sustituidos a partir de materiales de partida con contenido de 2-alquil-4,4-dimetil-1,3-di oxanos.
MX2018016329A (es) Reaccion de prins e intermediarios utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.
BR112018006519A2 (pt) compostos de fórmula, processo para a síntese de compostos, compostos intermediários x, composição, utilização de um composto de fórmula, método para o combate de fungos e semente
CU20160003A7 (es) Pirazololpiridinaminas sustituidas
CR20170168A (es) FIBRAS DE POLIPROPILENO MEJORADAS, MÉTODOS PARA PRODUCIRLAS Y SUS USOS PARA lA PRODUCCIÓN DE PRODUCTOS DE FIBROCEMENTO
BR112015029399A2 (pt) produção em etapa única de uma composição de polipropileno
GB201319839D0 (en) Synthesis and use of glycoside derivatives of propofol
MX2017011407A (es) Metodo para producir esteres de tetrahidropiranilo.
MX2020009462A (es) Procesos para la preparación de compuestos de pirimidinilciclopentano.
IN2013MU01219A (es)
CL2022001806A1 (es) Método para producir derivado de difenilmetano.
AR102166A1 (es) Método de fabricación de un péptido derivado de tapsigargina
BR112019008420A2 (pt) processo para a preparação de 1-(4-clorofenil)pirazol-3-ol cristalino
BR112018012696A2 (pt) processo aperfeiçoado para fabricação de crotonilaminopiridinas
FR3015520B1 (fr) Procede de production d'ethanol utilisant des sucres a 5 et 6 atomes de carbone
FR3015519B1 (fr) Procede de production d'ethanol utilisant des sucres a 5 et 6 atomes de carbone
FR3015518B1 (fr) Procede de production d'ethanol utilisant des sucres a 5 et 6 atomes de carbone